Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


electroCore Inc. (ECOR) said that it has reached an agreement with Medistar2 PTY whereby Medistar will serve as the exclusive distributor of the gammaCore Sapphire non-invasive vagus nerve stimulator or nVNS in Australia, supplying therapy to patients suffering with primary headache disorders.


RTTNews | Feb 28, 2021 09:50PM EST

21:49 Sunday, February 28, 2021 (RTTNews.com) - electroCore Inc. (ECOR) said that it has reached an agreement with Medistar2 PTY whereby Medistar will serve as the exclusive distributor of the gammaCore Sapphire non-invasive vagus nerve stimulator or nVNS in Australia, supplying therapy to patients suffering with primary headache disorders.

The announcement follows the granting of regulatory approval from the Australian Therapeutic Goods Administration for the promotion and sale of the gammaCore Sapphire family of products.

The initial term of the deal is three years and contains customary terms and conditions, including minimum purchase commitments.

Read the original article on RTTNews ( https://www.rttnews.com/3173574/electrocore-announces-gammacore-sapphire-nvns-distribution-deal-with-medistar.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC